Novel Nanoparticle-based Contrast Agents for Preclinical MRI Studies at 1T: Research Applications in Placental Disorders from tigr Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 33 min 19 sec ✓ Published: 12-Mar-2020
Description: This webinar considered a new class of targeted, liposomal-gadolinium MRI contrast agents that do not cross the placental barrier for preclinical studies of placental vascular architecture and placental accreta, or invasive placentation. These studies are conducted on a 1T permanent magnet MRI instrument which has high sensitivity for this gadolinium-based contrast agent. Contrast‐enhanced magnetic resonance imaging (CE‐MRI) is a dynamic technique for imaging vasculature. However, currently
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)